RhumbLine Advisers
MURA

RhumbLine Advisers’s Mural Oncology MURA Stock Holding History

RhumbLine Advisers’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,786
Closed -$33.9K – 4284
2024
Q2 		$33.9K Sell
10,786
-13,089
-55% -$48.2K ﹤0.01% 3779
2024
Q1 		$117K Sell
23,875
-124
-0.5% -$602 ﹤0.01% 3391
2023
Q4 		$142K Buy
+23,999
New +$96.5K ﹤0.01% 3337

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

RhumbLine Advisers's MURA Position: Q3 2024 in Review

RhumbLine Advisers sold out of Mural Oncology (MURA) in Q3 2024, closing a stake of 10,786 shares — an estimated $33.9K sold.

RhumbLine Advisers first reported a position in MURA in Q4 2023 and held it in 3 quarters. The position peaked at $142K in Q4 2023. 74 funds tracked by Wall St. Rank hold MURA as of Q3 2024.

  • RhumbLine Advisers reported no remaining Mural Oncology position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 10,786 Mural Oncology shares in Q3 2024, an estimated $33.9K.
  • RhumbLine Advisers first reported a position in Mural Oncology in Q4 2023 and held it in 3 quarters.
  • RhumbLine Advisers's Mural Oncology position peaked at $142K in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.